Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | LOX | P28300 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16874960 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL5672462 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL3198374 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL4098679 | 0.89 | ALDH1A1 (0.71) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL17997014 | 0.84 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL64436 | 0.83 | ALDH1A1 (0.63) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL41372 | 0.83 | ALDH1A1 (0.82) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL8521424 | 0.82 | LOX (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL14374993 | 0.82 | ALDH1A1 (0.62) | ALDH1A1CYP3A4CYP2C9CYP2C19LMNA | |
| SCHEMBL1939147 | 0.82 | PLCG1 (0.55) | ALDH1A1LMNAHPGDKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10287313-B2 | RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2019-05-14 | — | — | US | claimed |
| EP-2748176-B1 | IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV (CA) | 2019-04-17 | — | — | EP | claimed |
| US-20160340382-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2016-11-24 | — | — | US | claimed |
| EP-2334692-B1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | UNIV MCGILL (CA) | 2016-04-13 | — | — | EP | claimed |
| US-9249175-B2 | RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays | THE ROYAL INSTITUTE FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2016-02-02 | — | — | US | claimed |
| EP-2639307-B1 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORP (JP) | 2015-03-04 | — | — | EP | claimed |
| US-20120178638-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-07-12 | — | — | US | claimed |
| EP-2334692-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | The Royal Institution for the Advancement of Learning / McGill University (CA) | 2011-06-22 | — | — | EP | claimed |
| WO-2010025566-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2010-03-11 | — | — | WO | claimed |
| EP-3862431-B1 | METHOD FOR PRODUCING HAIRPIN SINGLE-STRAND RNA MOLECULES | TORAY INDUSTRIES (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-20240167033-A1 | METHOD OF PRODUCING HAIRPIN SINGLE-STRANDED RNA MOLECULE | TORAY INDUSTRIES, INC. (JP) | 2024-05-23 | — | — | US | disclosed |
| WO-2024106539-A1 | LIGAND CONJUGATE SUBSTANCE, NUCLEIC ACID CONTAINING SAME, AND USE THEREOF | 株式会社ボナック | 2024-05-23 | — | — | WO | disclosed |
| WO-2024101446-A1 | MODIFIED NUCLEOSIDE HAVING GUANIDINO STRUCTURE IN BRIDGED PART AND METHOD FOR PRODUCING OLIGONUCLEOTIDE USING SAME | ルクサナバイオテク株式会社 | 2024-05-16 | — | — | WO | disclosed |
| EP-3659609-B1 | THERAPEUTIC AGENT FOR FIBROSIS | KYORIN SEIYAKU KK (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-20080102281-A1 | MULTIFUNCTIONAL SELF-DECONTAMINATING SURFACE COATING | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-05-01 | — | — | US | disclosed |
| US-7339015-B2 | Multifunctional self-decontaminating surface coating | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2008-03-04 | — | — | US | disclosed |
| US-7294716-B2 | Process for preparing isomerically pure prodrugs of proton pump inhibitors | ALLERGAN, INC. (US) | 2007-11-13 | — | — | US | disclosed |
| WO-2007064291-A1 | METHOD AND COMPOUNDS FOR RNA SYNTHESIS | CHATTOPADHYAYA JYOTI (SE) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007064291-A1 | METHOD AND COMPOUNDS FOR RNA SYNTHESIS | CHATTOPADHYAYA JYOTI (SE) | 2007-06-07 | — | — | WO | disclosed |
| US-20070122438-A1 | Multifunctional self-decontaminating surface coating | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10287313-B2 | RNA monomers containing 0-acetal levulinyl ester groups and their use in RNA microarrays | EFTUD2, RNMT, NSUN2 | ALDH1A1 199/4885CYP3A4 3560/4885CYP2C9 3723/4885 |
| US-20160340382-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | EFTUD2, RNMT, RNGTT | ALDH1A1 212/4885CYP3A4 3599/4885CYP2C9 3789/4885 |
| US-20070122438-A1 | Multifunctional self-decontaminating surface coating | YWHAZ, EPCAM, LBR | ALDH1A1 2502/4885CYP3A4 3092/4885CYP2C9 3016/4885 |
| US-20120178638-A1 | RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS | EFTUD2, RNMT, RNGTT | ALDH1A1 212/4885CYP3A4 3599/4885CYP2C9 3789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.